C-Reactive Protein and Coronary Disease Is There a Causal Link?

被引：41

作者：

Danesh, John ^{[1
]}

Pepys, Mark B. ^{[2
]}

机构：

[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England

[2] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, London, England

来源：

CIRCULATION | 2009年 / 120卷 / 21期

基金：

英国医学研究理事会; 英国惠康基金;

关键词：

Editorials; coronary disease; epidemiology; heart diseases; myocardial infarction; risk factors; LOW-DENSITY-LIPOPROTEIN; AMYLOID-A-PROTEIN; E-DEFICIENT MICE; HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS DEVELOPMENT; MENDELIAN RANDOMIZATION; ARTERY-DISEASE; RISK;

D O I：

10.1161/CIRCULATIONAHA.109.907212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2036 / 2039

页数：4

共 45 条

[21] Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein - A meta-analysis [J].

Kinlay, Scott .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (20) :2003-2009

[22] Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits [J].

Koike, Tomonari ;

Kitajima, Shuji ;

Yu, Ying ;

Nishijima, Kazutoshi ;

Zhang, Jifeng ;

Ozaki, Yukio ;

Morimoto, Masatoshi ;

Watanabe, Teruo ;

Bhakdi, Sucharit ;

Asada, Yujiro ;

Chen, Y. Eugene ;

Fan, Jianglin .

CIRCULATION, 2009, 120 (21) :2088-U53

[23] Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia [J].

Kovacs, Alexander ;

Tornvall, Per ;

Nilsson, Roland ;

Tegner, Jesper ;

Hamsten, Anders ;

Bjorkegren, Johan .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (34) :13768-13773

[24]

Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963

[25] THE PROGNOSTIC VALUE OF C-REACTIVE PROTEIN AND SERUM AMYLOID-A PROTEIN IN SEVERE UNSTABLE ANGINA [J].

LIUZZO, G ;

BIASUCCI, LM ;

GALLIMORE, JR ;

GRILLO, RL ;

REBUZZI, AG ;

PEPYS, MB ;

MASERI, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (07) :417-424

[26] C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice [J].

Paul, A ;

Ko, KWS ;

Li, L ;

Yechoor, V ;

McCrory, MA ;

Szalai, AJ ;

Chan, L .

CIRCULATION, 2004, 109 (05) :647-655

[27] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].

Pearson, TA ;

Mensah, GA ;

Alexander, RW ;

Anderson, JL ;

Cannon, RO ;

Criqui, M ;

Fadl, YY ;

Fortmann, SP ;

Hong, Y ;

Myers, GL ;

Rifai, N ;

Smith, SC ;

Taubert, K ;

Tracy, RP ;

Vinicor, F .

CIRCULATION, 2003, 107 (03) :499-511

[28]

PEPYS MB, 1985, INT REV EXP PATHOL, V27, P83

[29] Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself [J].

Pepys, MB ;

Hawkins, PN ;

Kahan, MC ;

Tennent, GA ;

Gallimore, JR ;

Graham, D ;

Sabin, CA ;

Zychlinsky, A ;

de Diego, J .

CIRCULATION RESEARCH, 2005, 97 (11) :E97-E103

[30] C-reactive protein: a critical update [J].

Pepys, MB ;

Hirschfield, GM .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1805-1812

← 1 2 3 4 5 →